NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/13/2021
Back to search
Official data from USPTO
AGMASET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
01/13/2021
Trademark type
Word
Nice classes
5
Filing date
12/24/2010
Registration date
07/19/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2021
Last transaction
01/13/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/01/2010
First use in commerce
12/01/2010
Drawing code
4
Owner type
01
Owner location
Henderson, NV
Examiner
POVARCHUK, REBECCA
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
G. M. (pessoa física)
G. M. (pessoa física)
G. V. (pessoa física)
G. V. (pessoa física)
Representatives
GAD M. GILAD, PhD
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Antidiabetic preparations; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary drink mix for use as a meal replacement; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for aiding nerve health; Feed supplements for petslivestock; Food supplements; Food supplements for aiding nerve health; Foods for individuals with special dietary requirements necessitated by medical treatments; Health food supplements; Homeopathic supplements; Liquid nutritional supplement; Meal replacement and dietary supplement drink mixes; Medicated supplements for foodstuffs for animals; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for aiding nerve health; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional additives for medical purposes used in foods and dietary supplements for human consumption; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements; Nutritional supplements for aiding nerve health; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Ophthalmic preparations; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention of nervous system damage; Pharmaceutical preparations for the treatment and prevention of nervous system damage; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of nervous system damage; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for nervous system damage; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsantidepressants; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Powdered nutritional supplement drink mix; Preparation for the relief of pain; Therapeutic pharmaceutical for the treatment of nervous system damage; Veterinary preparations for nervous system damage; Veterinary preparationspain relief medication; Vitamins and dietary food supplements for animals
Publications
History of USPTO decisions and trademark events.
19 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/13/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/13/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/13/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
10/20/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/19/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/28/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2016
E815
TEAS SECTION 8 & 15 RECEIVED
07/24/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/24/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/19/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
07/19/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2011
PUBO
PUBLISHED FOR OPPOSITION
05/03/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2011
DOCK
ASSIGNED TO EXAMINER
03/23/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2011
NWAP
NEW APPLICATION ENTERED
12/28/2010
Continuous trademark protection
Get notified about every new filing that threatens AGMASET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.